Background
Introduction
5-Fluorouracil (5-FU) is a popular and effective chemotherapy drug that is recommended in the treatment of many types of cancers, including colon cancer, breast cancer, and head and neck cancers [1] . However, many adverse effects, such as mucositis, myelosuppression, headaches, dermatitis, photophobia, diarrhea, and cardiotoxicity can occur during the therapeutic period [1, 2] . About 20% to 40% of patients experience oral mucositis (OM) when receiving conventional chemotherapy, and a high-dose protocol can even produce severe OM rates in approximately 80% of patients [3] . OM is a painful lesion characterized by erythema or ulceration of the oral mucosa, and local or systemic infections will sequentially develop on the injured mucosal barrier [4] . This disease is not only associated with symptoms of discomfort and the lowering of patients' life quality, but also significantly increases hospital costs as well as prohibiting cancer treatment [5] [6] [7] .
Historically, chemotherapy-induced OM was believed to be an epithelium-mediated event, which represented the consequence of the nonspecific harmful effects on stem cell differentiation [8] . The renewal capacity of the epithelium will be deprived after this kind of direct damage to the basal epithelial cell layer by chemotherapy drugs, resulting in clonogenic cell death, mucosal atrophy, and consequent ulceration [9] . Although direct cell injury is the critical first step to initiate the process of OM, the pathological mechanism of cytotoxic agents related to OM is very complex. Several authors have suggested that reactive oxygen species generated by cyclooxygenase-2 and inducible nitric oxide synthase in injured cells leads to the development of OM [10, 11] . Subsequently, the expression of pro-inflammatory cytokines, such as tumor necrosis factor-α (TNF-α) and interleukin-1 (IL-1), are increased significantly [9, 12] . Logan et al. [11] stated the expression of nuclear factor-kappaB was increased significantly according to the post-chemotherapy immunohistochemistry (IHC) stain of biopsies from twenty chemotherapy-induced OM patients. Moreover, Sonis [9] concluded TNF-α could give a positive feedback to NF-κB and amplify its response, and as a result mitogen-activated protein kinase signaling could be activated. Due to the development of genetic screening tools in the past decade, genes involving in the chemotherapy-induced OM have also been delineated [13] .
In spite of the fact that the microarray has become a popular investigation tool in the research of chemotherapy-induced OM [14, 15] , the pivotal molecules and the relationship between these activated genes are still not clearly understood, and improved treatment compounds that target at the pivotal molecules of OM remain to be developed. The purpose of this study was to investigate the host responses after 5-FU administration, with the aim to find the target genes and their relationship with other cytokines in the 5-FU-induced OM mouse model through transcriptomic analysis. We investigated the fundamental impacts of the 5-FUaffected transcriptomic pattern and expect that our findings would be helpful for future cancer therapy research.
Materials and Methods

Animal experiments
Mouse experiments were controlled under the ethics approval from China Medical University Animal Ethics Committee (Permit Number: 97-28-N) and the study was performed in accordance with the guidelines laid down by the National Institute of Health in the USA regarding the care and use of animals for experimental procedures. BALB/c mice were obtained from National Laboratory Animal Center (Taipei, Taiwan).
The 5-FU-induced OM mouse animal model was modified according to a previous 5-FUinduced OM study [16] . Thirty-six 6 to 8 week-old male mice were randomly divided into two groups, including 18 mice for the control group and 18 mice for the 5-FU group, and they were administered intraperitoneally (i.p.) with phosphate-buffered saline (PBS) (137 mM NaCl, 1. 
Macroanalysis and histological examination
Mice were subjected to blinded macroscopic oral mucosal assessment on day 3, day 10, day 17, day 31, and day 45. Macroscopic assessment of the OM severity was scored based on a previous study [10] , and the average points were calculated and recorded. The criteria we used to investigate the macroscopic damage and the numerical rating score were as follows: 0, normal oral cavity; 1, presence of erythema and hyperemia; 2, presence of hemorrhagic areas or small ulcerations; and 3, extensive ulcerations or abscesses. In histological examination, at least three of the 5-FU-treated mice were sacrificed in every indicated period. After fixing the oral mucosal samples in 10% (v/v) phosphate-buffered formalin solution for 2 days, the samples were rinsed in saline, and sequentially dehydrated in a series of graded alcohols (50% (v/v), 70% (v/v), and 95% (v/v)) for 30 minutes each. They were then embedded in paraffin, cut into 5-μm sections, stained with hematoxylin and eosin (H&E), and subjected to blinded histological assessment. Histological changes were graded semi-quantitatively from 0 to 4 which were adapted from a previous study [10] . Briefly, the criteria we used to investigate the microscopic change were as follows: 0, normal epithelium and connective tissue; 1, discreet vasodilatation and inflammatory infiltration with mononuclear prevalence; 2, moderate vasodilatation and inflammatory infiltration with neutrophil prevalence, and the presence of hemorrhagic areas, and edema; 3, severe vasodilatation and inflammatory infiltration with neutrophil prevalence, and the presence of hemorrhagic areas, edema and ulceration but no abscesses; and 4, severe vasodilatation and inflammatory infiltration with neutrophil prevalence, and the presence of hemorrhagic areas, edema and extensive ulceration and abscesses.
Microarray analysis
Total RNA was extracted from each mouse's oral mucosa using RNeasy Mini kit (Qiagen, Valencia, CA, USA), and the total RNA was then quantified and evaluated. Microarray analysis was executed as previously described [17, 18] . Briefly, after the fluorescent-labeled, RNA targets were produced from 5 μg of total RNA by MessageAmp aRNA kit (Ambion, Austin, TX, USA) and Cy5 dye (Amersham Pharmacia, Piscataway, NJ, USA), they were hybridized to the Mouse Whole Genome OneArray (Phalanx Biotech Group, Hsinchu, Taiwan), and an Axon 4000 scanner (Molecular Devices, Sunnyvale, CA, USA) was applied to scan all of the samples. At least three replicates were accomplished from each mouse. The Genepix 4.1 software (Molecular Devices) was applied to examine the Cy5 fluorescent intensity of each spot, and the spots that had a signal-to-noise ratio of less than 0 or the control probes would be filtered out. The others that met the requirements of these criteria were normalized by R program [19] . The normalized signal intensities of genes in 5-FU-treated mice were divided with those in PBS-treated mice to calculate the fold changes of genes. The Transcription Regulation algorithm in the MetaCore Analytical suite (GeneGo Inc., St. Joseph, MI, USA) was used to generate the biological network which input genes were selected as fold changes 2 or -2.
Quantitative real-time PCR (qPCR)
The expression levels of Chitinase 3-like 4 (Chi3l4) and Bone gamma-carboxyglutamate protein, related sequence 1 (Bglap-rs1) genes were validated by qPCR. RNA samples were transcribed reversely for 2 hours at 37°C with the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Foster City, CA, USA) and the qPCR was executed by using 1 μl of cDNA, 2× SYBR Green PCR Master Mix (Applied Biosystems), with 200 nM of forward and reverse primers. The reaction condition was followed: 10 minutes at 95°C; 40 cycles of 95°C for 15 seconds; 1 minute at 60°C. Each assay was run on an Applied Biosystems 7300 Real-Time PCR system in triplicates. Fold changes were calculated using the comparative C T method. The primer sets for each gene were as follows: Bglap-rs1 forward, 5
0 -GACCCTCTCTCTGCTCAC
Immunohistochemical staining
Mice were treated with 5-FU and their oral mucosa was collected 5 weeks later for IHC staining. Briefly, parafilm-embedded oral mucosa was cut into 5-μm sections, incubated with anticluster of differentiation 11b (anti-CD11b), anti-IL-1β, anti-TNF-α, or anti-Bglap-rs1 antibodies (Santa Cruz, Dallas, TX, USA) overnight at 4°C, and then incubated with biotinylated secondary antibodies (Zymed Laboratories, Carlsbad, CA, USA). Finally, sections were incubated with avidin-biotin complex and stained with 3,3'-diaminobenzidine (Histostain-Plus, Zymed Laboratories, Carlsbad, CA, USA). The proportions of positive area (%) were calculated using ImageJ (http://imagej.nih.gov/ij/index.html).
Statistical analysis
Data were presented as mean ± standard error. The Student's t-test was used to find comparisons between the two experiments. A value of p<0.05 was considered statistically significant.
Results
Macroanalysis and histological examination of the oral mucosa following administration of 5-FU
When compared with the control group, on the oral mucosa of mice intraperitoneally administrated with 5-FU we found significant lesions (p<0.05) in macroanalysis, which were represented mostly by prominent erythema. Significant clinical signs were found two weeks after 5-FU administration (p<0.05) (Fig 1A) . However, no lesion presented hemorrhages, extensive ulcers, and abscesses in macroanalysis during the experimental period.
In the fifth week, histological examination of the oral mucosa of mice administrated with 5-FU showed remarkable vasodilatation, intense inflammation with neutrophil prevalence, hemorrhagic areas, edema, and extensive ulcers, when compared with the control group (Fig 1B) . These findings indicated that the intraperitoneal injection of 5-FU did induce mucosal damage and subsequent tissue inflammation. From the histological examination and scoring system, we observed that the inflammatory process had become significant since the third week onwards (p<0.05) and the severity of OM persisted until the seventh week during the experimental period (Fig 1C) .
Transcriptomic analysis of oral mucosa after 5-FU was administered
Microarray data were computed by the Gene Expression Pattern Analysis Suite v3.1 to test for the gene expressed with fold changes >2.0 or -2.0 in the mouse oral mucosa with 5-FUinduced OM. In a total of 30,968 genes, the transcripts of 19 genes were significant expressed in the 5-FU-treated group (Table 1 ). The microarray data were then analyzed by the Parametric Gene Set Enrichment Analysis (PGSEA) package of a bioconductor program to get enriched gene sets for the mice of 5-FU-induced OM, and we found Bglap-rs1 and Chi3l4 were significantly down-regulated (-12.69-fold and −6.35-fold when compared with the control group, respectively). Table 1 listed the gene sets in lesion with 5-FU-induced OM of mice.
Through the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis, we learned that twenty-three pathways were significantly involved in the 5-FU-induced OM model (Table 2 ). For example, the epidermal growth factor (EGF) signaling pathway (p = 0.0007233), the granulocyte colony-stimulating factor (G-CSF) signaling pathway (p = 0.016483), and the transforming growth factor beta 1 (TGF-β1) signaling pathway (p = 0.038104) were related with epithelial healing, blood cell maturation, and epithelial cell mitosis inhibition, respectively; more details are shown in Table 2 .
Verification of the target genes by qPCR
According to qPCR analysis, we discovered that Bglap-rs1 and Chi3l4 had significantly different gene expression in the 5-FU-treated group. To quantify these two gene expressions, we calculated that the chemotherapy drug 5-FU down-regulated the Bglap-rs1 and Chi3l4 gene expressions in 0.62-and 0.13-fold respectively, and both of them were significantly down-regulated in the 5-FU-treated group compared with the control group (p<0.01) ( Table 3) .
Immunohistochemical staining analysis of oral mucosa following 5-FU administration IHC staining was performed to verify 5-FU-induced inflammation in oral mucosa. CD11b is the marker of monocytes and granulocytes. The increase of CD11b-positive area in oral mucosa after 5-FU treatment (p<0.01) suggested the infiltration of inflammatory cells (Fig 2) . Moreover, the production of pro-inflammatory cytokines, such as IL-1β and TNF-α, was The oral cavity of each mouse was evaluated. Erythema and hyperemia of oral mucosa were significantly observed in the second week after 5-FU administration (p<0.05). During the third to seventh week period, the significant difference between 5-FU-induced oral mucositis increased (p<0.001 and p<0.05, respectively), which suggests that 5-FU-induced inflammation in oral mucosa. In addition, the Bglap-rs1-positive area decreased in oral mucosa (p<0.01), confirming that 5-FU down-regulated the expression of the Bglap-rs1 gene in 5-FU treated oral mucosa.
Discussion
5-FU is a chemotherapy medicine frequently used for the treatment of colon, breast, and head and neck malignancies. It eliminates cancerous cells through impeding DNA and protein synthesis [1] . However, OM and diarrhea are common side effects, which occur in about 80% of patients receiving 5-FU therapy. In this study, the pathological change of 5-FU-induced OM was investigated at indicated periods by both macroanalysis and histological examination; thus, the specimens could be obtained according to the severity of 5-FU-induced OM for further transcriptomic analysis. During the experimental period, the severity of OM progressed with increasing time. In the histological examination, the oral mucosa of 5-FU-treated group showed remarkable vasodilatation, intense inflammation with neutrophil prevalence, hemorrhagic areas, edema, and extensive ulcers in the fifth week. Additionally in the IHC stain, CD11b, a marker of monocytes and granulocytes, and two important pro-inflammatory cytokines, IL-1β and TNF-α, were all significantly up-regulated in this phase. These findings are in and the control group (mock) persisted (p<0.01). (B) Microscopic features of the oral mucosa. In the fifth week, three mock mice and four 5-FU-treated mice were sacrificed and the sections were stained with H&E and observed using light microscope. Magnification 100×. Photos are representative images. Histopathologically, the oral mucosa of mice subjected to 5-FU-induced oral mucositis showed accentuated vasodilatation, intense cellular infiltration with neutrophil prevalence, hemorrhagic areas, edema, and extensive ulcers, compared with the control group (mock). (C) According to the oral mucositis microscopic analysis scoring system, a significant difference was noted in the third week for the first time (p<0.05), and the peak influence was noted in the fifth week (p<0.01). Then the inflammatory condition was relieved in the seventh week investigation (red column: 5-FU treatment; green column: mock, the control group). Values are mean ± standard error. *p<0.05, **p<0.01, compared with the control group (mock). agreement with previous studies [9, 20] and therefore we suggest that 5-FU is a potent chemotherapy agent in inducing OM [21] . Although OM change was significantly observed in the second week according to macroanalysis, this result was compatible with a previous study with human subjects [8] . However, no hemorrhages, extensive ulcers, or abscesses were found in macroanalysis, which we suggest might be due to the smaller oral cavities and lack of cheek pouches in mice. Many researches used DNA microarray to investigate gene expression patterns and forecasted the clinical outcome and prognosis of patients receiving chemotherapy [22, 23] . In our previous study, we used the microarray tool to identify that the nuclear factor-κB may be the pivot molecule in the 5-FU-induced intestinal mucositis development [24] . In this study, we further investigated the cell response after 5-FU stimulation, and found that Chi3l4 and Bglaprs1 are significantly down-regulated in the mouse animal model of 5-FU-induced OM.
According to KEGG pathway analysis of the genes involved in the 5-FU-induced OM model, we learned that OM is a very complex inflammatory process and discovered twentythree pathways that participated significantly. For example, EGF signaling pathway controls many cellular processes including epithelial cell proliferation, migration, and survival [25] . Several reports concluded decreased salivary EGF is related with more severe OM [26, 27] , and found EGF plays a role in accelerated wound healing and tissue regeneration [28] . G-CSF not only plays an important role in the maturation of bone marrow progenitor cells to form neutrophils, basophils, and eosinophils, but also contributes to the stimulation of fibroblast and epithelial cell regeneration by augmenting IL-1 transcription and translation in OM [29] . Consequently, G-CSF [30] and IL-1 [31] were suggested to have roles in prevention and treatment of OM. Moreover, CD11b was suggested to be a marker of activation of neutrophils and macrophages, and the quantity of CD11b in neutrophils represented their activation in the inflammatory process [32] . Several reports also demonstrated G-CSF is a potent stimulator for the expression of CD11b on the surface of neutrophils [33, 34] . In this study, both CD11b and IL-1β were significantly activated and neutrophil prevalence was discovered indicated the inflammatory property of 5-FU-induced OM. Therefore, we suggest that G-CSF could play an important role in 5-FU-induced OM. TGF-β1 is the main form of TGF-β in keratinocytes [35] ; it is able to play as an antiproliferative factor in epithelial cells and endothelial cells. These cells will be arrested in the G1-phase, hence, TGF-β is supposed to have the possibility to reduce OM [36] . Taken together, these participated pathways provide researchers with a novel route to seek effective therapeutics for chemotherapy-induced OM. Many agents have been investigated to ameliorate the course of OM, such as Keratinocyte growth factors [37] , EGF [38] , G-CSF [39] , and TGF-β [40] . In this study many valuable pathways were identified, and we hope these findings could highlight the treatment path of chemotherapy-induced OM in the future.
Chi3l4 is a kind of chitinase-like proteins (CLPs) in rodents, and it has been proposed that Chi3l4 participates in the processes of the carbohydrate metabolism, chitin catabolism, and inflammatory response [41] . Webb et al. [42] suggested IL-4 might increase the expression of Chi3l4 mRNA in a STAT6-dependent fashion in the mouse model of ovalbumin-induced allergic airway inflammation. The main producers of Chi3l4 are macrophages, dermal, mast cells, and dendritic cells, and Chi3l4 is determined to contribute to the process of fibrosis and tissue repair, thus resulting in remodeling of the extracellular matrix [43] . Additionally, Qureshi et al. [44] revealed overexpression of CLPs in the dermis of the nasopharyngeal carcinoma mouse model, and they stated that CLPs are critical therapeutic targets to limit inflammation in cancer. In this study, the Chi3l4 gene was significantly down-regulated after 5-FU administration; we suggest that 5-FU could be a potent CLPs inhibitor and it might have a chance to become a more effective drug in cancer therapy. Furthermore, since expression of Chi3l4 plays a role in tissue repair, we also suggest the down-regulation of Chi3l4 after 5-FU administration might contribute to the development of 5-FU-induced OM. The human osteocalcin gene, Bglap, is secreted mainly by normal maturing osteoblasts and controls the dynamic process of bone resorption and new bone formation [45] . When Bglap is expressed, it also improves proliferation, adhesion, and the survival of tumor cells [46] . In contrast to Bglap, TNF-α plays an anti-tumor role, and it is able to inhibit the expression of Bglap [47] . Bglap is regarded as a TNF-α target and indirectly suggests a tumor-promoting function in cancers. There are three osteocalcin genes in mice, including osteocalcin gene 1, osteocalcin gene 2, and Bglap-rs1 [48] . In this study, TNF-α was significantly expressed in the IHC stain and Bglap-rs1 was significantly suppressed both in qPCR analysis and the IHC stain, hence we suggest there might be a connection between up-regulation of TNF-α and down-regulation of Bglap-rs1 in the 5-FU-induced OM mouse animal model. This condition might decelerate the process of oral mucosa regeneration and remodeling, and therefore OM could occur.
Since 5-FU-induced OM is a common medical problem, a number of approaches to manage the early oral mucosal changes by cytotoxic therapy have been proposed in current medical practices [49, 50] . However, it is hard to find an effective pharmacologic or biologic agent for OM, because the cellular pathological mechanism is not yet clearly understood. In this study we found CD11b and two important pro-inflammatory cytokines, IL-1β and TNF-α, and twenty-three pathways that were significantly involved in the process of 5-FU-induced OM, and some of the growth factors have been proposed to ameliorate the severity of chemotherapy-induced OM, such as EGF, G-CSF, and TGF-β. Furthermore, we discovered two significantly down-regulated genes, Chi3l4 and Bglap-rs1, in the 5-FU-induced OM model, and suggest that they are relevant to the cytotoxic effect of 5-FU. According to previous studies, we suggest that these two genes might play a part in tissue homeostasis. The significant suppression of Chi3l4 and Bglap-rs1 might prohibit the process of tissue remodeling, as a consequence, ulceration in oral mucosa could easily form and the OM lesion could be more susceptible to bacterial infection in this situation.
Conclusion
To our knowledge, this was the first report that comprehensively investigated the gene expression in 5-FU-induced OM mouse animal model. We demonstrated several valuable pathways, and some of the growth factors proposed have treatment potential according to previous studies. We also verified the important roles of CD11b, IL-1β and TNF-α in 5-FU-induced OM. In addition, two significantly down-regulated genes, Chi3l4 and Bglap-rs1, were discovered and we suggest that they might play a part in the process of 5-FU-induced OM.
